Type to search

Swissmedic Authorizes Moderna’s Omicron-targeting Bivalent Booster Candidate, mRNA-1273.214 | Pharmtech Focus
James Mock Joins Moderna as Chief Financial Officer | Pharmtech Focus
Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-containing Bivalent Booster in the UK | Pharmtech Focus